EFFECTIVENESS OF RABEPRAZOLE FOR THE TREATMENT OF ACID-RELATED DISEASES
Vladislav Vladimirovich Tsukanov, Э. В. Каспаров, Alexander Viktorovich Vasyutin, Yu.L. Tonkikh, O. V. Peretyatko
Abstract
Open-access reader
Vladislav Vladimirovich Tsukanov, Э. В. Каспаров, Alexander Viktorovich Vasyutin, Yu.L. Tonkikh, O. V. Peretyatko
Abstract
Open-access reader
The analysis of modern data about the effectiveness of rabeprazole in the treatment of acid-related diseases is performed. The European Consensus Maastricht 5 recommends a preferred use of rabeprazole in the schemes of eradication of Helicobacter pylori. Clinical studies confirmed the high efficiency of rabeprazole for the treatment of GERD, and prevention of NSAID-induced gastropathy. Modern and effective generic of rabeprazole is Rabiet.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The analysis of modern data about the effectiveness of rabeprazole in the treatment of acid-related diseases is performed. The European Consensus Maastricht 5 recommends a preferred use of rabeprazole in the schemes of eradication of Helicobacter pylori. Clinical studies confirmed the high efficiency of rabeprazole for the treatment of GERD, and prevention of NSAID-induced gastropathy. Modern and effective generic of rabeprazole is Rabiet.
Key concepts: Rabeprazole, Helicobacter pylori, Medicine, GERD, Gastroenterology, Internal medicine, Disease, Reflux